Digital Heart Summit 2024: Pioneering the Future of Cardiology Through Digital Innovation Renowned Experts Discuss the Current Obstacles in Implementing eHealth
The Digital Heart Summit 2024, held in Berlin on October 25-26th, concluded with resounding success, bringing together leading minds in eHealth to explore the cutting-edge innovations in digital cardiology. The summit attracted over 100 cardiologists, researchers, and tech innovators from across Europe, making it an excellent platform for interactive exchange and diverse insights in this fast-evolving field.
Throughout the two-day event, attendees engaged in discussions on the latest advancements in artificial intelligence, telemedicine, and wearable health devices. These technologies are aimed at improving heart health and revolutionizing patient care. A focal point of the summit was the state of telecardiology in Europe. Experts provided in-depth analysis of successfully implementing telecardiology projects in their countries. They shared the lessons learnt and future challenges.
"The Digital Heart Summit has once again underlined the need for innovative solutions in the field of telecardiology.”, Prof. Gerhard Hindricks, Head of Rhythmology & Chief Integration Officer (Charite University Hospital & Deutsches Herzzentrum Berlin) sums up. “The insights and ideas shared over the past two days will undoubtedly shape the future of cardiac care and help us bring eHealth into wider adoption globally."
During the summit, BIOTRONIK showcased its inCareNet Heart Failure solution, focusing on expanding its telemedicine presence. It currently monitors over 10,000 patients in Germany, reinforcing its position as a market leader.
“Digital innovation in cardiology is no longer a distant vision—it is a reality that is already delivering tangible benefits,” explains Roberto Belke, Managing Director at BIOTRONIK, Germany. “With our advanced digital health tools, we aim to lead the way in transforming the monitoring and treatment of cardiac patients.”
-END-
About the Digital Heart Summit:
The way we communicate and how patients are cared for has changed significantly in recent years. With a new event series – Digital Heart Summit – we aim to highlight digital trends and developments in cardiology and discuss innovative concepts for improving care. In keeping with the current zeitgeist, we will bring together users, decision-makers, and patients from around the world, either virtually or in person, to actively shape the cardiology of the future.
About BIOTRONIK:
At BIOTRONIK, patient well-being is our top priority and has been for 60 years. BIOTRONIK is a leading global medical technology company with products and services that save and improve the lives of millions suffering from heart and blood vessel diseases as well as chronic pain. Driven by a purpose to perfectly match technology with the human body, we are dedicated innovators who develop trusted cardiovascular, endovascular and neuromodulation solutions. BIOTRONIK is headquartered in Berlin, Germany, and is represented in over 100 countries.
More Press Releases
-
Image
SINGAPOREPress ReleaseBIOTRONIK Opens New Asia-Pacific Hub in Singapore
BIOTRONIK announced today the opening of its new Asia Pacific Manufacturing and Research Hub. The 20,000 m² site will serve as the company’s central hub in Asia-Pacific, with hundreds of employees working in manufacturing, quality, research & development (R&D), and sales and marketing. BIOTRONIK, founded in Berlin, Germany, in 1963 is a pioneer in implantable pacemakers, defibrillators, and vascular intervention for 60 years. BIOTRONIK’s presence in Singapore began in 2012, and in 2016, the company inaugurated its first manufacturing site, complementing its high-quality manufacturing sites in
-
Image
BERLIN, GermanyPress ReleaseAI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions
The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled clinical TIMELY trial. The TIMELY study investigates to what extent the AI-supported TIMELY platform improves the health of myocardial infarction (MI) patients and other patients with coronary heart disease after cardiac rehabilitation. Around 1.8 million people in the European Union die each year from coronary heart disease. 1 To prevent reinfarctions, patients receive cardiac rehabilitation to support necessary changes in lifestyle habits, such as diet and increased physical activity
-
Image
StatementA Message to Our Valued Customers and Their Patients
As the COVID-19 pandemic continues, we are conscious of the enormous strain that you are all under. We share your concerns about the spread of the virus and the disruption it is causing globally. We are doing what we can to help minimize this disruption and to provide support so that you can focus on the critical task of saving lives. To this end, we would like to inform you of the following: